(19)
(11) EP 2 035 574 A1

(12)

(43) Date of publication:
18.03.2009 Bulletin 2009/12

(21) Application number: 07725942.2

(22) Date of filing: 11.06.2007
(51) International Patent Classification (IPC): 
C12Q 1/37(2006.01)
 G01N 33/574(2006.01)
(86) International application number:
PCT/EP2007/005118
(87) International publication number:
WO 2007/147496 (27.12.2007 Gazette 2007/52)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR
Designated Extension States:
AL BA HR MK RS

(30) Priority: 17.06.2006 EP 06012459

(71) Applicant: Bayer HealthCare AG
51368 Leverkusen (DE)

(72) Inventors:
  • GOLZ, Stefan
    45326 Essen (DE)
  • BRÜGGEMEIER, Ulf
    42799 Leichlingen (DE)
  • GEERTS, Andreas
    42113 Wuppertal (DE)

   


(54) USE OF N-ACYLAMINOACYLPEPTIDE HYDROLASE (APEH) AS A THERAPEUTIC OR DIAGNOSTIC TARGET